Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Tax Provisions (2016 - 2019)

IGC Pharma has reported Tax Provisions over the past 9 years, most recently at $2000.0 for Q1 2019.

  • Quarterly Tax Provisions changed N/A to $2000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $2000.0 for FY2019, N/A changed from the prior year.
  • Tax Provisions was $2000.0 for Q1 2019 at IGC Pharma, up from -$1.1 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $445000.0 in Q4 2015 and troughed at -$1.4 million in Q1 2016.
  • The 4-year median for Tax Provisions is $2014.5 (2015), against an average of -$330826.8.
  • Year-over-year, Tax Provisions surged 140.68% in 2015 and then crashed 70993.1% in 2016.
  • A 4-year view of Tax Provisions shows it stood at $445000.0 in 2015, then plummeted by 83.6% to $73000.0 in 2016, then crashed by 1563.79% to -$1.1 million in 2017, then soared by 100.19% to $2000.0 in 2019.
  • Per Business Quant, the three most recent readings for IGC's Tax Provisions are $2000.0 (Q1 2019), -$1.1 million (Q1 2017), and $73000.0 (Q4 2016).